WAYRILZ™ (rilzabrutinib), FDA-Approved for Treatment of Adults with Immune Thrombocytopenia, Available at Biologics by McKesson
Biologics by McKesson was selected as a limited specialty pharmacy provider for WAYRILZ, an oral BTK inhibitor for adults with persistent or chronic immune thrombocytopenia.